A Post-Marketing Surveillance Study to Assess the Safety of Oral Azacitidine Maintenance Therapy in Korean Patients With Acute Myeloid Leukemia

NCT06073769 · clinicaltrials.gov ↗

RECRUITING

Status

154

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: Oral azacitidine

Sponsor

Bristol-Myers Squibb